ExamFinch.com My Study

Study guide

CARN-AP study guide

Read a lesson, then practice the ideas you want to remember.

Practice this exam

Lessons

  1. Alcohol-Associated Liver Disease: Staging, S
  2. Cardiovascular, Oncologic & Nutritional Cons
  3. Brief Intervention, Drinking Goals & Shared
  4. Relapse Prevention, Mutual-Help Programs & R
  5. APRN Scope of Practice, Prescriptive Authori
  6. Ethical Dilemmas in Addictions Nursing: Stig
  7. Harm Reduction Philosophy, Syringe Service P
  8. Landmark Clinical Trials & Research Literacy
  9. Alcohol Withdrawal Syndrome, CIWA-Ar Protoco
  10. AUD Neurobiology, Epidemiology, Screening In
  11. Wernicke-Korsakoff Syndrome, High-Dose Paren
  12. Low-Dose Micro-Induction & Fentanyl Transiti
  13. Buprenorphine Pharmacology, Standard Office/
  14. Long-Acting Injectable Buprenorphine & Exten
  15. Cannabinoid Pharmacology, Potency & the Mode
  16. Cannabis Use Disorder: Epidemiology, Assessm
  17. Medical Cannabis, Legalization Policy, Adole
  18. About the CARN-AP Examination: Blueprint, Sc
  19. The Neurobiology of Addiction: Binge, Withdr
  20. Screening, SBIRT & the ASAM Criteria Levels
  21. Integrated Dual Diagnosis Treatment Framewor
  22. Trauma-Informed Care, PTSD, and Addictions:
  23. Complex Severe Mental Illness: Psychotic Dis
  24. Acute Pain Management in Patients on Mainten
  25. CDC 2022 Clinical Practice Guideline for Pre
  26. Multimodal Non-Opioid Pharmacotherapy, Inter
  27. The APRN Consultation Process & Communicatin
  28. Interprofessional Collaboration, Care Coordi
  29. Community Resources, Systems Navigation & Co
  30. Decisional Capacity, Competency, and Involun
  31. Endocrine, Neurological, and Metabolic Mimic
  32. Diagnostic Formulation: Primary vs. Substanc
  33. Family & Support-System Education: CRAFT, Al
  34. Designing Health Teaching: Literacy, Readine
  35. Medication Education, Informed Consent & Inf
  36. Public, Professional & Anticipatory Guidance
  37. Outcome Measurement & Continuous Quality Imp
  38. Policy Advocacy, Leadership & the Determinan
  39. Acamprosate Calcium: NMDA Modulation, Renal
  40. Oral and Injectable Naltrexone for AUD: Mech
  41. Disulfiram and Second-Line / Off-Label MAUDs
  42. Hallucinogens & Dissociatives: Classic Psych
  43. Inhalant Use Disorder: Volatile Solvents, Ni
  44. Prescription & Over-the-Counter Substance Mi
  45. Process Addictions: Gambling Disorder, Gamin
  46. Methadone Pharmacology, OTP Federal Regulati
  47. Opioid Overdose Assessment, Harm Reduction,
  48. OUD Assessment, DSM-5-TR Diagnostic Criteria
  49. Infectious Complications in People Who Injec
  50. Neonatal Abstinence Syndrome: Finnegan Scori
  51. Perinatal Substance Use Disorder: ACOG/ASAM
  52. Controlled Substances Act, DEA Registration,
  53. Confidentiality of Substance Use Disorder Pa
  54. Prescription Drug Monitoring Programs & Urin
  55. Methamphetamine Use Disorder: Pharmacology,
  56. Stimulant Harm Reduction, Overamping & Patie
  57. Pharmacotherapy Research for Stimulant Use D
  58. Stimulant Withdrawal, Craving & Contingency
  59. Sedative, Hypnotic, and Anxiolytic Disorders
  60. Stimulant Use Disorder: Neurotoxicity, Medic
  61. Emerging Synthetic Drugs: Fentanyl Analogues
  62. Behavioral Therapies in Substance Use: Motiv
  63. Cannabis Use Disorder, Synthetic Cannabinoid
  64. Tobacco Use Disorder & Nicotine Dependence:
  65. Nicotine Neurobiology, Epidemiology & the To
  66. Tobacco Assessment & Behavioral Treatment: 5
  67. Tobacco Treatment in Special Populations & C